Article Details

Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual ...

Retrieved on: 2022-12-01 13:01:24

Tags for this article:

Click the tags to see associated articles and topics

Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual .... View article details on hiswai:

Excerpt

... a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up